Live Breaking News & Updates on Instruments Segment

Stay updated with breaking news from Instruments segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

These Analysts Revise Their Forecasts On Thermo Fisher Scientific Following Upbeat Earnings - Thermo Fisher Scientific (NYSE:TMO)

....

Catherine Schulte , Marc Casper , Thermo Fisher , Jp Morgan , Biopharma Services , Life Sciences Solutions Segment , Thermo Fisher Scientific Inc , Laboratory Products , Fisher Scientific , Instruments Segment , Diagnostics Segment , Thermo Fisher Scientific , Tycho Peterson ,

Thermo Fisher Lifts Annual Forecast On Improved Demand, Despite Q1 Revenue Dip

On Wednesday, Thermo Fisher Scientific Inc. (NYSE: TMO) posted a first-quarter revenue of $10.34 billion, down 3% year over year, beating the consensus of… ....

Life Sciences Solutions Segment , Thermo Fisher Scientific Inc , Thermo Fisher Scientific , Instruments Segment , Reaking News ,

Thermo Fisher Lifts Annual Forecast On Improved Demand, Despite Q1 Revenue Dip - Thermo Fisher Scientific (NYSE:TMO)

Discover Thermo Fisher Scientific Inc's (NYSE: TMO) Q1 earnings: $10.34 billion revenue, down 3% Y/Y, with beats in EPS and guidance. Dive into details now. ....

Marc Casper , Biopharma Services , Life Sciences Solutions Segment , Thermo Fisher Scientific Inc , Thermo Fisher , Laboratory Products , Thermo Fisher Scientific , Instruments Segment , Diagnostics Segment ,

Medical Equipment Maker Thermo Fisher Scientific Clocks 7% Decline In Q4 Organic Sales, Issues Subdued Annual Outlook - Thermo Fisher Scientific (NYSE:TMO)

"Thermo Fisher Scientific surpasses Q4 revenue expectations at $10.89B, down 5% YoY. Analytical Instruments Segment rises 8.5%. Financial highlights and 2024 revenue guidance. ....

Marc Casper , Thermo Fisher Scientific Inc , Life Sciences Solutions Segment , Laboratory Products , Thermo Fisher , Biopharma Services , Instruments Segment , Diagnostics Segment ,

Lab Equipment Provider Thermo Fisher's Stock Falls On Revised Q4 Outlook, CEO Cites Challenging Environment - Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific Inc (NYSE: TMO) posted Q3 revenue of $10.574 billion, down 1% Y/Y, missing the  ....

Marc Casper , Laboratory Products , Biopharma Services , Life Sciences Solutions Segment , Thermo Fisher , Instruments Segment , Diagnostics Segment ,